PDF herunterladen
Am J Perinatol 2016; 33(13): 1313-1318
DOI: 10.1055/s-0036-1586500
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Endocrine Disruptors: A Potential Risk Factor for Gestational Diabetes Mellitus

Shelley Ehrlich
1   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
,
Donna Lambers
2   Department of Maternal-Fetal Medicine, Good Samaritan Hospital, TriHealth, Cincinnati, Ohio
,
Andrea Baccarelli
3   Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York
,
Jane Khoury
1   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
,
Maurizio Macaluso
1   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
,
Shuk-Mei Ho
4   Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio
› Institutsangaben
Weitere Informationen

Publikationsverlauf

28. April 2016

21. Juni 2016

Publikationsdatum:
04. August 2016 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Gestational diabetes mellitus (GDM) has increased dramatically in the past 20 years together with the obesity epidemic. Mirroring the increase in incidence of GDM is increasing use of endocrine disrupting chemicals (EDCs). EDCs are structurally similar to endogenous hormones and interfere with synthesis, secretion, activity, or elimination of natural hormones, resulting in adverse health effects, including diabetes, obesity, developmental disorders, etc. Although the association between bisphenol A (BPA), a well-studied EDC, and type 2 diabetes has been repeatedly investigated in epidemiological and animal studies, there is a dearth of studies examining EDCs and GDM. In fact, the impact of environmental toxins on perinatal health outcomes has largely been overlooked.

Recognizing this research gap, the American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, and International Federation of Gynecology and Obstetrics recently joined leading scientists and clinicians in a call for action to prioritize research in the consequences of exposure to toxic environmental agents on women's health. Evidence is emerging to suggest signaling molecules and EDCs are involved in the control of microRNA (miRNA) expression in trophoblast cells. We reviewed existing scientific evidence of EDCs as a risk factor for GDM as well as the potential role of miRNA in this association.

Keywords

gestational diabetes mellitus - endocrine disruptors - miRNA - environmental - epigenetic - biomarkers
 

  • References

  • 1 Coustan DR, Lowe LP, Metzger BE, Dyer AR ; International Association of Diabetes and Pregnancy Study Groups. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 2010; 202 (6) 654.e1-654.e6
    CrossrefPubMedGoogle Scholar
  • 2 Hunt KJ, Logan SL, Conway DL, Korte JE. Postpartum screening following GDM: how well are we doing?. Curr Diab Rep 2010; 10 (3) 235-241
    CrossrefPubMedGoogle Scholar
  • 3 Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart 2013; 99 (15) 1118-1121
    CrossrefPubMedGoogle Scholar
  • 4 Connolly N, Anixt J, Manning P, Ping-I Lin D, Marsolo KA, Bowers K. Maternal metabolic risk factors for autism spectrum disorder-An analysis of electronic medical records and linked birth data. Autism Res 2016; (e-pub ahead of print)
    PubMedGoogle Scholar
  • 5 Vandorsten JP, Dodson WC, Espeland MA , et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013; 29 (1) 1-31
    PubMedGoogle Scholar
  • 6 Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 2011; 73: 135-162
    CrossrefPubMedGoogle Scholar
  • 7 Chevalier N, Fénichel P. Endocrine disruptors: new players in the pathophysiology of type 2 diabetes?. Diabetes Metab 2015; 41 (2) 107-115
    CrossrefPubMedGoogle Scholar
  • 8 Park SH, Ha EH, Hong YS, Park H. Serum levels of persistent organic pollutants and insulin secretion among children aged 7 to 9 years: a prospective cohort study. Environ Health Perspect 2016; (e-pub ahead of print)
    PubMedGoogle Scholar
  • 9 Shapiro GD, Dodds L, Arbuckle TE , et al. Exposure to phthalates, bisphenol A and metals in pregnancy and the association with impaired glucose tolerance and gestational diabetes mellitus: the MIREC study. Environ Int 2015; 83: 63-71
    CrossrefPubMedGoogle Scholar
  • 10 Robledo C, Peck JD, Stoner JA , et al. Is bisphenol-A exposure during pregnancy associated with blood glucose levels or diagnosis of gestational diabetes?. J Toxicol Environ Health A 2013; 76 (14) 865-873
    CrossrefPubMedGoogle Scholar
  • 11 Lang IA, Galloway TS, Scarlett A , et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300 (11) 1303-1310
    CrossrefPubMedGoogle Scholar
  • 12 Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 2010; 5 (1) e8673
    CrossrefPubMedGoogle Scholar
  • 13 Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol 2009; 304 (1–2) 49-54
    CrossrefPubMedGoogle Scholar
  • 14 Peretz J, Vrooman L, Ricke WA , et al. Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect 2014; 122 (8) 775-786
    PubMedGoogle Scholar
  • 15 ACOG Committee Opinion No. 575. Exposure to toxic environmental agents. Obstet Gynecol 2013; 122 (4) 931-935
    CrossrefPubMedGoogle Scholar
  • 16 Di Renzo GC, Conry JA, Blake J , et al. International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int J Gynaecol Obstet 2015; 131 (3) 219-225
    CrossrefPubMedGoogle Scholar
  • 17 Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2 (8) 569-579
    CrossrefPubMedGoogle Scholar
  • 18 Chen X, Liang H, Zhang J, Zen K, Zhang CY. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 2012; 3 (1) 28-37
    CrossrefPubMedGoogle Scholar
  • 19 Zhao C, Dong J, Jiang T , et al. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS ONE 2011; 6 (8) e23925
    CrossrefPubMedGoogle Scholar
  • 20 Li J, Song L, Zhou L , et al. A microRNA signature in gestational diabetes mellitus associated with risk of macrosomia. Cell Physiol Biochem 2015; 37 (1) 243-252
    CrossrefPubMedGoogle Scholar
  • 21 Avissar-Whiting M, Veiga KR, Uhl KM , et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 2010; 29 (4) 401-406
    CrossrefPubMedGoogle Scholar
  • 22 Dolinoy DC. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev 2008; 66 (Suppl. 01) S7-S11
    CrossrefPubMedGoogle Scholar
  • 23 Donker RB, Mouillet JF, Chu T , et al. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod 2012; 18 (8) 417-424
    CrossrefPubMedGoogle Scholar
  • 24 Carwile JL, Luu HT, Bassett LS , et al. Polycarbonate bottle use and urinary bisphenol A concentrations. Environ Health Perspect 2009; 117 (9) 1368-1372
    CrossrefPubMedGoogle Scholar
  • 25 Carwile JL, Ye X, Zhou X, Calafat AM, Michels KB. Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA 2011; 306 (20) 2218-2220
    CrossrefPubMedGoogle Scholar
  • 26 Sasaki N, Okuda K, Kato T , et al. Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med 2005; 16 (4) 297-300
    CrossrefPubMedGoogle Scholar
  • 27 Ehrlich S, Calafat AM, Humblet O, Smith T, Hauser R. Thermal receipt handling and BPA: a simulation cross-over study. JAMA 2014; 311 (8) 859-860
    CrossrefPubMedGoogle Scholar
  • 28 Philippat C, Wolff MS, Calafat AM , et al. Prenatal exposure to environmental phenols: concentrations in amniotic fluid and variability in urinary concentrations during pregnancy. Environ Health Perspect 2013; 121 (10) 1225-1231
    PubMedGoogle Scholar
  • 29 Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008; 116 (1) 39-44
    PubMedGoogle Scholar
  • 30 Calafat AM, Wong LY, Ye X, Reidy JA, Needham LL. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003–2004. Environ Health Perspect 2008; 116 (7) 893-897
    CrossrefPubMedGoogle Scholar
  • 31 Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ Health Perspect 2008; 116 (3) 303-307
    PubMedGoogle Scholar
  • 32 Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect 2010; 118 (5) 679-685
    CrossrefPubMedGoogle Scholar
  • 33 Diamanti-Kandarakis E, Bourguignon JP, Giudice LC , et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009; 30 (4) 293-342
    CrossrefPubMedGoogle Scholar
  • 34 vom Saal FS, Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 2005; 113 (8) 926-933
    CrossrefPubMedGoogle Scholar
  • 35 Hectors TL, Vanparys C, van der Ven K , et al. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia 2011; 54 (6) 1273-1290
    CrossrefPubMedGoogle Scholar
  • 36 Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006; 114 (1) 106-112
    CrossrefPubMedGoogle Scholar
  • 37 Song Y, Chou EL, Baecker A , et al. Endocrine disrupting chemicals, risk of type 2 diabetes, and diabetes related metabolic traits: A systematic review and metaanalysis. J Diabetes 2016; 8 (4) 516-532
    CrossrefPubMedGoogle Scholar
  • 38 Salomon C, Sobrevia L, Ashman K , et al. The Role of Placental Exosomes in Gestational Diabetes Mellitus 2014. DOI: 10.5772/55298 (open access)
    PubMedGoogle Scholar
  • 39 Mitchell MD, Peiris HN, Kobayashi M , et al. Placental exosomes in normal and complicated pregnancy. Am J Obstet Gynecol 2015; 213 (4, Suppl) S173-S181
    CrossrefPubMedGoogle Scholar
  • 40 Luo SS, Ishibashi O, Ishikawa G , et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009; 81 (4) 717-729
    CrossrefPubMedGoogle Scholar
  • 41 Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, Schoenleben M, Markert UR. Pregnancy-associated miRNA-clusters. J Reprod Immunol 2013; 97 (1) 51-61
    CrossrefPubMedGoogle Scholar
  • 42 Gilad S, Meiri E, Yogev Y , et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008; 3 (9) e3148
    CrossrefPubMedGoogle Scholar
  • 43 Chen J, Tan B, Karteris E , et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006; 49 (6) 1292-1302
    CrossrefPubMedGoogle Scholar
  • 44 Pineles BL, Romero R, Montenegro D , et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 2007; 196 (3) 261.e1-261.e6
    CrossrefPubMedGoogle Scholar
  • 45 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (7) 768-773
    CrossrefPubMedGoogle Scholar
  • 46 LaRocca J, Binder AM, McElrath TF, Michels KB. First-trimester urine concentrations of phthalate metabolites and phenols and placenta miRNA expression in a cohort of U.S. women. Environ Health Perspect 2016; 124 (3) 380-387
    PubMedGoogle Scholar
  • 47 De Felice B, Manfellotto F, Palumbo A , et al. Genome-wide microRNA expression profiling in placentas from pregnant women exposed to BPA. BMC Med Genomics 2015; 8: 56
    CrossrefPubMedGoogle Scholar
  • 48 Huang H, Du G, Zhang W , et al. The in vitro estrogenic activities of triclosan and triclocarban. J Appl Toxicol 2014; 34 (9) 1060-1067
    CrossrefPubMedGoogle Scholar